Avalo Therapeutics, Inc.AVTXNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank15
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Percentile
P15
Within normal range
vs 3Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
2025-86.62%
2024-77.08%
2023-89.34%
2022234.40%
2021-19.42%
2020-0.76%
2019-63.17%
2018-34.11%
20172312.24%
20160.00%